Oramed Pharmaceuticals (ORMP) EBITDA Margin Growth (1y) (2017 - 2023)
Oramed Pharmaceuticals (ORMP) EBITDA Margin Growth (1y) (2017 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Oramed Pharmaceuticals |
151.47 Mn |
133.31 Mn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2023 |
113,145.00 |
| Mar 31, 2023 |
90,751.00 |
| Nov 30, 2019 |
27,789.00 |
| Aug 31, 2019 |
5,774.00 |
| May 31, 2019 |
12,724.00 |
| Feb 28, 2019 |
-438.00 |
| Nov 30, 2018 |
-27,740.00 |
| Aug 31, 2018 |
5,924.00 |
| May 31, 2018 |
-45,219.00 |
| Feb 28, 2018 |
-5,787.00 |
| Nov 30, 2017 |
8,158.00 |
| Aug 31, 2017 |
460,884.00 |
| May 31, 2017 |
-144,513.00 |
| Feb 28, 2017 |
89,855.00 |
